E. Ohman J:or Asset Management’s United Therapeutics UTHR Stock Holding History

E. Ohman J:or Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$824K	Hold	1,521	–	–	0.02%	331
2026 Q1	$902K	Hold	1,521	–	–	0.02%	296
2025 Q4	$741K	Buy	+1,521	New	+$708K	0.02%	350
2018 Q2	–	Sell	-1,100	Closed	-$124K	–	521
2018 Q1	$124K	Hold	1,100	–	–	0.01%	533
2017 Q4	$163K	Hold	1,100	–	–	0.01%	511
2017 Q3	$129K	Buy	1,100 +100	+10%	+$12.8K	0.01%	516
2017 Q2	$130K	Hold	1,000	–	–	0.01%	520
2017 Q1	$135K	Hold	1,000	–	–	0.02%	503
2016 Q4	$143K	Hold	1,000	–	–	0.02%	490
2016 Q3	$118K	Sell	1,000 -22,556	-96%	-$2.71M	0.02%	487
2016 Q2	$2.5M	Buy	23,556 +6,285	+36%	+$701K	0.41%	56
2016 Q1	$1.92M	Buy	17,271 +16,271	+1,627%	+$2.06M	0.35%	67
2015 Q4	$157K	Hold	1,000	–	–	0.03%	407
2015 Q3	$131K	Hold	1,000	–	–	0.04%	426
2015 Q2	$174K	Buy	+1,000	New	+$180K	0.04%	393

Other funds holding UTHR

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

E. Ohman J:or Asset Management's UTHR Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 1,521 shares worth $824K. The position accounts for 0.02% of the portfolio, ranked #331.

E. Ohman J:or Asset Management first reported a position in UTHR in Q2 2015 and has held it in 15 quarters since. The position peaked at $2.5M in Q2 2016. 273 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

E. Ohman J:or Asset Management held 1,521 shares of United Therapeutics worth $824K as of Q2 2026.
E. Ohman J:or Asset Management left its United Therapeutics share count unchanged in Q2 2026.
United Therapeutics made up 0.02% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #331 holding.
E. Ohman J:or Asset Management first reported a position in United Therapeutics in Q2 2015 and has held it in 15 quarters since.
E. Ohman J:or Asset Management's United Therapeutics position peaked at $2.5M in Q2 2016.
273 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.